- Home
- ARWR vs BUSE Comparison
ARWR vs BUSE Comparison
Compare ARWR & BUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- BUSE
- Stock Information
- Founded
- ARWR 2003
- BUSE 1868
- Country
- ARWR United States
- BUSE United States
- Employees
- ARWR N/A
- BUSE N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- BUSE Major Banks
- Sector
- ARWR Health Care
- BUSE Finance
- Exchange
- ARWR Nasdaq
- BUSE Nasdaq
- Market Cap
- ARWR 2.5B
- BUSE 2.1B
- IPO Year
- ARWR 1993
- BUSE N/A
- Fundamental
- Price
- ARWR $36.64
- BUSE N/A
- Analyst Decision
- ARWR Strong Buy
- BUSE Buy
- Analyst Count
- ARWR 8
- BUSE 7
- Target Price
- ARWR $47.75
- BUSE $27.43
- AVG Volume (30 Days)
- ARWR 2.4M
- BUSE 542.9K
- Earning Date
- ARWR 11-25-2025
- BUSE 10-28-2025
- Dividend Yield
- ARWR N/A
- BUSE 4.30%
- EPS Growth
- ARWR N/A
- BUSE N/A
- EPS
- ARWR N/A
- BUSE 1.13
- Revenue
- ARWR $572,976,000.00
- BUSE $498,525,000.00
- Revenue This Year
- ARWR $21,421.26
- BUSE $62.58
- Revenue Next Year
- ARWR N/A
- BUSE $11.64
- P/E Ratio
- ARWR N/A
- BUSE $20.65
- Revenue Growth
- ARWR 2816.20
- BUSE 16.77
- 52 Week Low
- ARWR $9.57
- BUSE $18.40
- 52 Week High
- ARWR $39.42
- BUSE $28.30
- Technical
- Relative Strength Index (RSI)
- ARWR 73.44
- BUSE 39.25
- Support Level
- ARWR $36.29
- BUSE $22.73
- Resistance Level
- ARWR $39.38
- BUSE $23.70
- Average True Range (ATR)
- ARWR 1.39
- BUSE 0.48
- MACD
- ARWR 0.06
- BUSE -0.14
- Stochastic Oscillator
- ARWR 69.44
- BUSE 17.84
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech and Wealth Management. The banking segment generates a vast majority of its revenue.